Anticorps Polyclonal de lapin anti-IL-17A

IL-17A Polyclonal Antibody for IHC, ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain et plus (1)

Applications

WB, IHC, IF, ELISA

Conjugaison

Non conjugué

Publications(62)

N° de cat : 13082-1-AP

Synonymes

CTLA 8, CTLA8, IL 17, IL 17A, IL17, IL-17, IL17A, interleukin 17A

---

Galerie de données de validation

• 

  IHC staining of human colon cancer using 13082-1-AP

  Immunohistochemical analysis of paraffin-embedded human colon cancer tissue slide using 13082-1-AP (IL-17A antibody at dilution of 1:200 (under 10x lens).

• 

  IHC staining of human colon cancer using 13082-1-AP

  Immunohistochemical analysis of paraffin-embedded human colon cancer tissue slide using 13082-1-AP (IL-17A antibody at dilution of 1:200 (under 40x lens).

• 

  IHC staining of human colon using 13082-1-AP

  Immunohistochemical analysis of paraffin-embedded human colon tissue slide using 13082-1-AP (IL-17A antibody) at dilution of 1:500 (under 10x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of human colon using 13082-1-AP

  Immunohistochemical analysis of paraffin-embedded human colon tissue slide using 13082-1-AP (IL-17A antibody) at dilution of 1:500 (under 40x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of human cervical cancer using 13082-1-AP

  Immunohistochemical analysis of paraffin-embedded human cervical cancer tissue slide using 13082-1-AP (IL-17A antibody) at dilution of 1:200 (under 10x lens. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of human cervical cancer using 13082-1-AP

  Immunohistochemical analysis of paraffin-embedded human cervical cancer tissue slide using 13082-1-AP (IL-17A antibody) at dilution of 1:200 (under 40x lens. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of human stomach cancer using 13082-1-AP

  Immunohistochemical analysis of paraffin-embedded human stomach cancer tissue slide using 13082-1-AP (IL-17A antibody) at dilution of 1:200 (under 10x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of human stomach cancer using 13082-1-AP

  Immunohistochemical analysis of paraffin-embedded human stomach cancer tissue slide using 13082-1-AP (IL-17A antibody) at dilution of 1:200 (under 40x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

---

Applications testées

• Résultats positifs en IHC: tissu de cancer du côlon humain, tissu de cancer de l'estomac humain, tissu de cancer du col de l'utérus humain, tissu de côlon humain; il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0.

Dilution recommandée

• Immunohistochimie (IHC): IHC : 1:50-1:500

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Applications publiées

• WB: See 16 publications below
• IHC: See 34 publications below
• IF: See 12 publications below
• FC: See 1 publications below

Informations sur le produit

13082-1-AP cible IL-17A dans les applications de WB, IHC, IF, ELISA et montre une réactivité avec des échantillons Humain

• Réactivité: Humain
• Réactivité citée: Humain, Lapin
• Hôte / Isotype: Lapin / IgG
• Clonalité: Polyclonal
• Type: Anticorps
• Immunogène: IL-17A Protéine recombinante Ag3733
• Nom complet: interleukin 17A
• Masse moléculaire calculée: 155 aa, 18 kDa
• Numéro d’acquisition GenBank: BC067505
• Symbole du gène: IL-17A
• Identification du gène (NCBI): 3605
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Purification par affinité contre l'antigène
• Tampon de stockage: PBS with 0.02% sodium azide and 50% glycerol
• Conditions de stockage: Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20^oC Les 20ul contiennent 0,1% de BSA.

Informations générales

IL17A, also named as IL-17, is a proinflammatory cytokine. IL-17, synthesized only by memory T cells and natural killer cells, has pleiotropic effects, mainly in the recruitment and activation of neutrophils. This cytokine regulates the activities of NF-kappaB and mitogen-activated protein kinases. This cytokine can stimulate the expression of IL6 and cyclooxygenase-2 (PTGS2/COX-2), as well as enhance the production of nitric oxide (NO). High levels of this cytokine are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis and multiple sclerosis. The IL-17 receptor is a type I transmembrane protein, that is widely expressed on epithelial cells, fibroblasts, B and T cells, and monocytic cells. In psoriatic skin lesions, both Th17 cells and their downstream effector molecules, e.g. IL-17 and IL-22, are highly increased. This antibody got 32-35 kDa band in western blot, maybe due to homodimer formation and differential glycosylations.

Publications

Species	Application	Title
	WB	Brain Behav Immun; Egln3 expression in microglia enhances the neuroinflammatory responses in Alzheimer's disease; Authors - Jiaxin Guan
	WB	Int J Biol Macromol; Chitosan-modified dihydromyricetin liposomes promote the repair of liver injury in mice suffering from diabetes mellitus; Authors - Qiteng Ding
human	IF	J Autoimmun; IL-17 is expressed on beta and alpha cells of donors with type 1 and type 2 diabetes.; Authors - Sakthi Rajendran
	WB	J Med Chem; Discovery of Orally Available Retinoic Acid Receptor-Related Orphan Receptor γ-t/Dihydroorotate Dehydrogenase Dual Inhibitors for the Treatment of Refractory Inflammatory Bowel Disease.; Authors - Ji-An Chen
	IHC	J Invest Dermatol; Reduced Il17a expression distinguishes a Ly6c(lo)MHCII(hi) macrophage population promoting wound healing.; Authors - Rodero Mathieu P MP
	IF	Arch Oral Biol; Age-related changes of CD4+ T cell migration and cytokine expression in germ-free and SPF mice periodontium.; Authors - Koichiro Irie

{{ptg:RelatedPrimaryAntibodies}}